Jerilyn (Jeri) A. Logemann
Department of Communication Sciences and Disorders
Professor of Otolaryngology-Head & Neck Surgery and Neurology, Ralph and Jean Sundin Professor in Communication Sciences and Disorders
Ralph & Jean Sundin Professor
j-logemann@northwestern.edu
Frances Searle Building
2240 Campus Drive, Room 3-358
Evanston, IL 60208-3507
847-491-2490
Graduate Programs: Communication Sciences and Disorders
Jeri Logemann's research interests include the management of voice disorders, normal swallowing physiology, the assessment and treatment of speech and swallowing dysfunction in treated head and neck cancer patients and neurologically-impaired individuals, and in the development of randomized clinical trials. Logemann developed the modified barium swallow test, a less stressful alternative to a typical radiographic study of swallowing, which encourages patients’ participation and allows for treatment of swallowing problems right in the X-ray room.
Lab Affiliation
Swallow Physiology Lab
Education
| |
NINCDS Post Doctoral Fellowship |
| PhD |
Speech-Language Pathology, Northwestern University |
| MA |
Speech-Language Pathology, Northwestern University |
| BA |
Speech-Language Pathology, Northwestern University |
Publications
Publications List [pdf]
Recent Awards and Honors
| |
Fellow, American Speech-Language-Hearing Association |
| |
Fellow, Chicago Medical Society |
| 2003 |
Honors of the American Speech-Language-Hearing Association |
| 2007 |
Honors of the Illinois Speech-Language-Hearing Association |
Recent Grants and Funding
| 2001-2011 |
Evaluation and Treatment of Swallowing Disorders in Patients with Parkinson's Disease. NIH/NCI. $81,846. Co-investigator |
| 2006-2011 |
Oropharyngeal Function After Radiotherapy with IMRT, NIH/NIDCD, $494, 171. Principal Investigator. |
| 2007-2012 |
Efficacy of Electrical Stimulation for Dysphagia in Head and Neck Cancer Patients, NIH/NCI, $87,145. Co-investigator |
| 2007-2008 |
Multi-center, Blinded, Pilot Comparison of the Effects of Two Formulations of Botulinum Toxin Type A on Oropharyngeal Swallowing Efficiency in Patients with Cervical Dystonia — A Procedural Protocol (MedAff-BTX-0617). Allergan, Inc. $116,490. Principal Investigator. |
Courses
| CSD 438-1 |
Dysphagia: Diagnosis and Treatment of Swallowing Disorders |
| CSD 438-2 |
Problem Solving in Patient Management of Dysphagia |
| CSD 450 |
Research to Practice in SLP |